Literature DB >> 6454516

Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.

A G Bird, L Hammarström, C I Smith, S Britton.   

Abstract

The polyclonal T lymphocyte activators Con A and PHA were demonstrated to induce secretion of IgM and IgG as well as IgA antibodies in cultures of human peripheral blood lymphocytes. A similar response was seen in one-way mixed lymphocyte cultures and the kinetics, dose-response characteristics and optimal culture conditions are presented. The presence of functional T lymphocytes is a prerequisite for in vitro B lymphocyte activation in response to T lymphocyte mitogens. A narrow dose-response profile is a characteristic for both Con A and PHA and polyclonal B cell activation occurred at what have been previously regarded as suboptimal concentrations of these agents. The use of higher doses of these activators failed to generate immunoglobulin-secreting cells despite the presence of early and optimal levels of DNA synthesis in the cultures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454516      PMCID: PMC1537136     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  A third signal in B cell activation given by TRF.

Authors:  A Schimpl; E Wecker
Journal:  Transplant Rev       Date:  1975

Review 2.  Functional analysis of murine and human B lymphocyte subsets.

Authors:  G Janossy; M Greaves
Journal:  Transplant Rev       Date:  1975

3.  Mitogens as probes for immunocyte activation and cellular cooperation.

Authors:  J Andersson; O Sjöberg; G Möller
Journal:  Transplant Rev       Date:  1972

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Lymphocyte activation. 3. Binding sites for phytomitogens on lymphocyte subpopulations.

Authors:  M F Greaves; S Bauminger; G Janossy
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

6.  Evidence for transformation of human B lymphocytes by PHA.

Authors:  B Phillips; I M Roitt
Journal:  Nat New Biol       Date:  1973-02-21

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Synergy between human T and B lymphocytes in their response to phythaemagglutinin and pokeweed mitogen.

Authors:  M E Weksler; M M Kuntz
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

9.  Proliferation of B and T cells in mixed lymphocyte cultures.

Authors:  L C Andersson; S Nordling; P Häyry
Journal:  J Exp Med       Date:  1973-07-01       Impact factor: 14.307

Review 10.  Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens.

Authors:  M Greaves; G Janossy; M Doenhoff
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  4 in total

1.  Klebsiella pneumoniae stimulate highly purified human blood B cells to mature into plaque forming cells without prior proliferation.

Authors:  W L Gross; A Rucks
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

2.  T-cell-dependent polyclonal activation by soluble mycobacterial extracts of B cells in peripheral blood mononuclear cell populations from leprosy patients and normal donors.

Authors:  B Fleming; G A Rook
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

3.  Detection of IgD-secreting human lymphocytes at the single cell level by a protein A plaque assay.

Authors:  C I Smith; L Hammarström; D Pettersson; H Mellstedt; G Holm
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

4.  Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation.

Authors:  Rina F Villar; Jinal Patel; Grant C Weaver; Masaru Kanekiyo; Adam K Wheatley; Hadi M Yassine; Catherine E Costello; Kevin B Chandler; Patrick M McTamney; Gary J Nabel; Adrian B McDermott; John R Mascola; Steven A Carr; Daniel Lingwood
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.